Literature DB >> 20079488

Allergen-specific B cell subset responses in cow's milk allergy of late eczematous reactions in atopic dermatitis.

Jae Ho Lee1, Joonyong Noh, Geunwoong Noh, Hyuk Soon Kim, Se Hwan Mun, Wahn Soo Choi, Sunheui Cho, Sangsun Lee.   

Abstract

B cells have regulatory functions in immune responses. Antigen-specific responses of B cell subsets by allergen stimulation ex vivo were examined in milk allergy of late eczematous reactions. Eight milk allergy subjects and 13 milk tolerant subjects were selected by DBPCFC. PBMCs were stimulated by casein ex vivo and stained for B cell subsets using monoclonal antibodies. CD19+ B cells unchanged from 8.7+/-3.8% to 8.0+/-5.1% (p=0.504, n=8) in the milk allergy group and decreased in the milk tolerant group from 8.5+/-3.2% to 5.0+/-1.6% (p=0.001, n=13). The fraction of apoptotic B cells in B cells significantly decreased 4.4+/-3.1% to 1.3+/-0.4% (p=0.027, n=4) in the allergy group and insignificantly increased from 2.8+/-0.6% to 5.4+/-2.6% (p=0.059, n=6) in the milk tolerant group. CD5+ regulatory B1 cell% in B cells decreased in milk allergy subjects from 36.2+/-5.0% to 31.0+/-5.7% (p=0.010) and unchanged in milk tolerant subjects from 41.6+/-10.2% to 43.8+/-10.0% (p=0.413). IL-10 producing CD19+CD5+ regulatory B cell% in CD19+CD5+ regulatory B cells significantly decreased from 24.9+/-6.5% to 13.8+/-5.6% (p=0.002, n=5) by casein stimulation in milk allergy group and unchanged from 44.8+/-11.3% to 43.9+/-10.0% (p=0.297, n=5) in the milk tolerant group. B cell subset responses to IL-4 and IL-5 were also similar in both groups. B cell subset changes seemed to have diagnostic value. Exact immunologic roles of regulatory CD5+ B1 cells need further investigation. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20079488     DOI: 10.1016/j.cellimm.2009.12.006

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  7 in total

Review 1.  Human regulatory B cells in health and disease: therapeutic potential.

Authors:  Claudia Mauri; Madhvi Menon
Journal:  J Clin Invest       Date:  2017-03-01       Impact factor: 14.808

2.  Peanut oral immunotherapy transiently expands circulating Ara h 2-specific B cells with a homologous repertoire in unrelated subjects.

Authors:  Sarita U Patil; Adebola O Ogunniyi; Agustin Calatroni; Vasisht R Tadigotla; Bert Ruiter; Alex Ma; James Moon; J Christopher Love; Wayne G Shreffler
Journal:  J Allergy Clin Immunol       Date:  2015-05-16       Impact factor: 10.793

3.  In Vitro Induction of Allergen-Specific Interleukin-10-Producing Regulatory B Cell Responses by Interferon-γ in Non-Immunoglobulin E-Mediated Milk Allergy.

Authors:  Soo Jin Lee; Geunwoong Noh; Jae Ho Lee
Journal:  Allergy Asthma Immunol Res       Date:  2012-09-27       Impact factor: 5.764

4.  Presence of Foxp3-expressing CD19(+)CD5(+) B Cells in Human Peripheral Blood Mononuclear Cells: Human CD19(+)CD5(+)Foxp3(+) Regulatory B Cell (Breg).

Authors:  Joonyong Noh; Wahn Soo Choi; Geunwoong Noh; Jae Ho Lee
Journal:  Immune Netw       Date:  2010-12-31       Impact factor: 6.303

5.  IL-10 is predominantly produced by CD19(low)CD5(+) regulatory B cell subpopulation: characterisation of CD19 (high) and CD19(low) subpopulations of CD5(+) B cells.

Authors:  Jae Ho Lee; Joonyong Noh; Geunwoong Noh; Wahn Soo Choi; Sang Sun Lee
Journal:  Yonsei Med J       Date:  2011-09       Impact factor: 2.759

6.  Mesenteric IL-10-producing CD5+ regulatory B cells suppress cow's milk casein-induced allergic responses in mice.

Authors:  A-Ram Kim; Hyuk Soon Kim; Do Kyun Kim; Seung Taek Nam; Hyun Woo Kim; Young Hwan Park; Dajeong Lee; Min Bum Lee; Jun Ho Lee; Bokyung Kim; Michael A Beaven; Hyung Sik Kim; Young Mi Kim; Wahn Soo Choi
Journal:  Sci Rep       Date:  2016-01-20       Impact factor: 4.379

7.  Modulating Oxidative Stress in B Cells Promotes Immunotherapy in Food Allergy.

Authors:  Hao-Tao Zeng; Yu Liu; Miao Zhao; Jiang-Qi Liu; Qiao-Ruo Jin; Zhi-Qiang Liu; Yan Li; Zhi-Gang Liu; Bai-Sui Feng; Pingchang Yang
Journal:  Oxid Med Cell Longev       Date:  2022-01-21       Impact factor: 6.543

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.